Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Pioglitazone × Clear all

NCT04995978 2023-06-23

Insulin Resistance and Androgen Deprivation Therapy

Phase 2 Withdrawn

Insulin Resistance, Prostatic Neoplasms